Membership
Yale Cancer Center (YCC) membership in one of the six research programs is open to faculty who meet the membership criteria and have a focus on cancer research or treatment. Through our six interdisciplinary Research Programs, members discover areas of joint interest and collaboration. Three types of membership are available: Full, Clinical, and Research. Applications are reviewed by Research Program leadership and the YCC Chair of the Membership Committee.
Research Program Leadership reviews active members annually to ensure ongoing adherence to membership requirements. YCC members are expected to contribute to the organization’s mission: "To reduce the burden of cancer in Connecticut and beyond through transformative science and community partnership, ensuring health equity and exceptional care for all.”
Member Eligibility
Full Membership
An independent Yale faculty appointment and must have contributed to the peer-reviewed cancer literature within the past three years and have one of the following:
1. Held extramural cancer-relevant peer-reviewed grant support as a PI, or as a Co-PI, within the past two years
or
2. Served as PI or Co-PI on one or more YCC intervention (therapeutic or non-therapeutic) cancer clinical trials within the preceding 24-month period. For this purpose, a PI or Co-PI should contribute to protocol development, implementation, and patient accrual.
or
3. Provided exceptional medical or scientific expertise to the overall research mission of the YCC.
Clinical Membership
Be affiliated with Yale University and provide substantive clinical, scientific, or administrative expertise in the cancer field.
Research Membership
Be affiliated with Yale University and provide substantive basic, population, scientific, or administrative expertise in the cancer field.
Clinical and Research Members must have one of the following:
Contribute to the peer-reviewed cancer literature.
Or
Participate on an extramural cancer-relevant peer-reviewed grant.
Or
Contribute to YCC intervention (therapeutic or non-therapeutic) cancer clinical trials.Clinical and Research Members must have one of the following: